Technical
Channels

Drug Delivery

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Pall presents five-year business plan


Dated: 11/18/2008

Pall Corp hosted an investor conference at the Grand Hyatt Hotel in New York City late last month.

The company presented its five-year strategic business plan for fiscal 2009 - 2013 to a group of financial analysts.

The presentation was also webcast live to a broader audience.

By the end of Pall's new five-year plan, sales CAGR is targeted to increase to between 7% and 9% with earnings per share ranging from $4.25 to $5.60, excluding restructuring and other charges and the impact of currency translation.

It has also updated guidance for fiscal 2009.

Sales are projected to grow between 4% and 6.5% with earnings per share of $2.10 to $2.30, excluding restructuring and other charges and the impact of currency translation.

The new plan calls for the establishment of a Swiss entity as part of the company's initiatives to rationalize its European infrastructure.

The new company, located in the canton of Fribourg, will lead and support sales, manufacturing, supply chain and other European functions.

The company also provided a target tax rate of 25-27% by fiscal 2013.

  Related Industry Links
 
Pharmaceutical Society of Hong Kong (China)
Organization of Pharmaceutical Producers of India
 
 

Reed Business Information Asia | EM Asia | EM Asia (China) | Control Engineering Asia | Asia Food Journal
Drug Discovery & Development | Genomics & Proteomics | Pharmaceutical Processing | R&D | BioScience Technology

 
ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US
   
 
© 2009 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
Use of this web site is subject to its Terms and Conditions of Use. View our Privacy Policy.